NCT02787967View on ClinicalTrials.gov

Clinical Pharmacology of 35/4 NEXThaler® in Children 5-11 Years Old

PHASE2CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions
Asthma
Interventions
DRUG

CHF 1535 35/4µg NEXThaler®

4 (four) inhalations (total dose: BDP/FF 140/16 µg)

DRUG

free comb. beclomethasone DPI and formoterol DPI

2 (two) inhalations BDP 100 µg DPI + 4 (four) inhalations FF 6 µg DPI (total dose: BDP 200 µg + FF 24 µg

Trial Locations (1)

Unknown

BørneAstmaKlinikken, Hans Knudsens Plads 1A,, Copenhagen

All Listed Sponsors
lead

Chiesi Farmaceutici S.p.A.

INDUSTRY

NCT02787967 - Clinical Pharmacology of 35/4 NEXThaler® in Children 5-11 Years Old | Biotech Hunter | Biotech Hunter